Isik, U. Et Al. 2019. Real life data from Turkey regarding the impact of first-line sunitinib and pazopanib in metastatic renal cell cancer.. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , (Illinois, United States Of America).

Isik, U., Kostek, O., Demiray, G., Dirican, A., Simsek, M., Buyuksimsek, M., ... Ucar, G.(2019). Real life data from Turkey regarding the impact of first-line sunitinib and pazopanib in metastatic renal cell cancer. . Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America

Isik, Ulas Et Al. "Real life data from Turkey regarding the impact of first-line sunitinib and pazopanib in metastatic renal cell cancer.," Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 2019

Isik, Ulas Et Al. "Real life data from Turkey regarding the impact of first-line sunitinib and pazopanib in metastatic renal cell cancer.." Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America, 2019

Isik, U. Et Al. (2019) . "Real life data from Turkey regarding the impact of first-line sunitinib and pazopanib in metastatic renal cell cancer.." Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America.

@conferencepaper{conferencepaper, author={Ulas Isik Et Al. }, title={Real life data from Turkey regarding the impact of first-line sunitinib and pazopanib in metastatic renal cell cancer.}, congress name={Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)}, city={Illinois}, country={United States Of America}, year={2019}}